Holen Sie sich die Stockscreener-App
3.69
0.82%
0.03
Schlusskurs vom Vortag:
$3.66
Offen:
$3.7
24-Stunden-Volumen:
24,911
Relative Volume:
0.69
Marktkapitalisierung:
$28.90M
Einnahmen:
$23.84M
Nettoeinkommen (Verlust:
$-3.81M
KGV:
-4.7922
EPS:
-0.77
Netto-Cashflow:
$-713.00K
1W Leistung:
+2.22%
1M Leistung:
+2.22%
6M Leistung:
-21.66%
1J Leistung:
-19.26%
1-Tages-Spanne:
$3.65
$3.75
1-Wochen-Bereich:
$3.40
$3.76
52-Wochen-Spanne:
$3.34
$5.59
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Vergleichen Sie ICCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ICCC | 3.69 | 28.90M | 23.84M | -3.81M | -713.00K | -0.77 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN
ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports recovery and strong demand for Q3 2024 - Investing.com
ICCCImmucell Corp Latest Stock News & Market Updates - StockTitan
ImmuCell Q3 Sales Jump 11% to $6M, Nine-Month Revenue Surges 51% Despite Net Loss | ICCC Stock News - StockTitan
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - StockTitan
ImmuCell reports 11% sales boost in third quarter - Investing.com
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - StockTitan
ImmuCell amends lease terms and by-laws - Investing.com
Healthcare Stock Performance - Yahoo Finance
IMMUCELL CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports growth amid operational challenges - Investing.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan
ImmuCell (ICCC) Scheduled to Post Earnings on Wednesday - Defense World
ImmuCell stock touches 52-week low at $3.92 amid market challenges - Investing.com
ImmuCell Corp hits 52-week low, trading at $4.05 - Investing.com
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga
ImmuCell reports robust sales growth in Q2 2024 - Investing.com
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - StockTitan
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Below Two Hundred Day Moving Average of $4.95 - Defense World
ImmuCell says Pfizer terminates contract on Mast Out - Reuters.com
Short Interest in ImmuCell Co. (NASDAQ:ICCC) Expands By 66.7% - Defense World
Rollins (NYSE:ROL) Upgraded to “Buy” at StockNews.com - Defense World
VBI Vaccines (NASDAQ:VBIV) Now Covered by Analysts at StockNews.com - Defense World
Immucell updates status of product development initiative for Re-TainTipRanks.com - TipRanks
ImmuCell progresses with FDA regulatory process for cattle health product By Investing.com - Investing.com Australia
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® - GlobeNewswire Inc.
ImmuCell progresses with FDA regulatory process for cattle health product - Investing.com
ImmuCell Corporation (NASDAQ:ICCC) Q1 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports sales increase to $7.2 million - Investing.com South Africa
Earnings call: ImmuCell reports sales increase to $7.2 million By Investing.com - Investing.com UK
ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript - Seeking Alpha
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 - Investing.com India
3 Magnificent S&P 500 Dividend Stocks Down 17% to 44% to Buy and Hold Forever - The Motley Fool
After-hours movers: SMART Global, PriceSmart, and more By Investing.com - Investing.com
Breeding innovation: Rarebreed grows out of Maine’s animal-health hub - Mainebiz
Bovine Mastitis Treatment System Market Analysis : US, Germany, France, India, ChinaForecast 2024-2028 - Technavio
Top 20 Animal Health Companies in the World - Insider Monkey
Today's Gap Up Stocks | Find Top Stocks Gapping Up Today - MarketBeat
‘Unleashing’ growth: Maine's emerging ‘Silicon Valley for animal health’ - Mainebiz
Democrat Jacky Rosen sees Big Pharma investments soar while urging lower drug prices - Washington Examiner
ImmuCell achieves USDA approval of new product claim - Feedstuffs
Jim Grasky named to senior role at Olympia Snowe Women's Leadership Institute - Press Herald
No. 1 in the Northeast: Maine startup business is region’s fastest-growing, says Inc. - Press Herald
UMass Amherst Allows Maine-based ImmuCell Corp. the Right to License New Bacteriocin Technology - UMass News and Media Relations
Biotechnology now employs nearly 10,000 workers in Maine - Press Herald
ImmuCell plans second expansion in three years as demand grows - Mainebiz
Portland-based biotech ImmuCell posts 45% sales increase for Q4 - Mainebiz
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):